Ganoderic Acid A targeting leucine-rich repeat kinase 2 involved in Parkinson's disease-A computational study.

could even be used to treat neurological disorders like PD. This study suggest that the best-identified molecule against LRRK2 is GAA and it needs rigorous in vitro and in vivo validations.